Illumina Ventures related stories
All articles and analysis
Sherlock Biosciences fetches $80m Series BSherlock Biosciences, a next-generation diagnostics company, has raised $80 million in Series B financing.
Walking Fish Therapeutics picks up $50m Series AWalking Fish Therapeutics, a B cell engineering company, has raised $50 million in Series A financing.
- Virtual care firm LetsGetChecked nets $150m Series D
LetsGetChecked, a virtual care company, has secured $150 million in Series D financing.
- VC-backed SQZ Biotech goes public
Watertown, Massachusetts-based SQZ Biotechnologies Company, a cell therapy company, has debuted its IPO after pricing its over 4.4 million shares at $16 per share.
- Illumina Ventures promotes one to partner
Illumina Ventures, a healthcare-focused venture firm, has promoted Wouter Meuleman to partner.
VC-backed Ribometrix appoints Phillips as COO and CFODurham, North Carolina-based Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, has named Barclay Phillips as chief operating officer and chief financial officer.
- Encoded Therapeutics scores $135m Series D
South San Francisco-based Encoded Therapeutics, a precision gene therapy company, has raised $135 million in Series D financing.
- Pattern Bioscience attracts $9m
Austin-based Pattern Bioscience, an in vitro diagnostics company, has raised $9 million in funding.
Illumina Ventures aims to make a differenceA healthcare investor in the San Francisco Bay Area has its eyes on investments in cutting-edge genomics. The firm says its focus is rewarding and meaningful.
- SQZ Biotech grabs $65m
Watertown, Massachusetts-based SQZ Biotechnologies Company, a cell therapy company, has raised $65 million in Series D preferred stock financing.